News About: Pharm. Affairs


No updates for settling balance for differences on targeted therapy for cancer ‘Tarceva’

The pharmaceutical distribution industry raised complaints since they have not been able to settle balance for differences generated by the drug price cut of ‘Tarceva,’ a Roche Korea’s targeted therapy for cancer. Th...

5-Year-Cyle Pharmaceutical Product Renewal System to be enforced from this June

A policy for pharmaceutical products to get approval and renewal every 5 years will be enforced from the coming June. The Ministry of Food and Drug Safety(MFDS) announced enforcement of the Pharmaceutical Product Ren...

‘Zemiglo’ license lawsuit meets new phase with Sanofi’s marketing data

At a lawsuit between LG Life Sciences and Sanofi-Aventis over close of the Zemiglo’s license, it seems a new phase is going to be developed as Sanofi turned in data about its marketing activity. The Civil Affairs Dep...

200 products approved by bioequivalent test this year, decreased by 29% year-on-year

The number of pharmaceutical products newly approved by bioequivalent test this year was 200 products, decreased by 29% compared to the same period of the last year. According to the Ministry of Food and Drug Safety,...

2018 health insurance contribution negotiation starts, “We ask for reasonable contributions”

Today(10th), the new government will focus on the 2018 health insurance contribution negotiation starting with a meeting with the National Health Insurance Service(NHIS) and heads of healthcare-related orgazniations. ...

Plan to nurture Advanced Medical Care Complex as global hub to lead Industry 4.0

The Ministry of Health and Welfare(MOHW) announced on the 8th that it decided the 3rd Comprehensive Plan(2017-2019) for the Advanced Medical Care Complex, which will be established to have services, such as efficacy a...

Sillajen’s co-development agreement of renal cancer treatment with U.S. RegeneronPharmaceuticals

Sillajen(CEO Eun-Sang Moon) announced in a joint statement on the 8th that it signed a co-research agreement of renal cell carcinoma(renal cancer) treatment development with U.S. ‘RegeneronPharmaceuticals.’ Under the...

Jeil enters hyaluronic acid filler market

Jeil Pharm(CEO/President Suk-Jae Sung) launched ‘Revanesse’ and ‘ReDexis,’ high-purity hyaluronic acid(HA) wrinkle fillers applied with the ‘Thixofix Cross-linking Technology,’ a patented technology developed by Canad...

Daehan New Pharm expands business into facial beauty market via BNC Korea

Daehan New Pharm will expand its business into the facial beauty market by getting an exclusive sales license of a Korean filler manufacturer. On the 27th, Daehan New Pharm announced it signed an exclusive sales agre...

Term ‘natural new medicine’ will disappear

In order to avoid misconception to ‘new drug’ defined in the Pharmaceutical Affairs Law, the term ‘natural new medicine(literal translation)’ will no longer be used. The Ministry of Food and Drug Safety(MFDS) pre-ann...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.